Investors encouraged to join DexCom class action lawsuit. Allegations include unapproved design changes to G6/G7 glucose ...
NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).
A Dexcom (NSDQ:DXCM) communication on its website states that it will soon cease manufacturing for its G6 continuous glucose ...
IEEE Spectrum on MSN
Why the most accurate glucose monitors are failing some users
For diabetics who rely on them, lived experience trumps metrics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results